GNOM vs VXUS
Global X Genomics & Biotechnology ETF vs Vanguard Total International Stock ETF
Quick Verdict
VXUS has a lower expense ratio. GNOM delivered stronger 1-year returns. VXUS offers more diversification with 7861 holdings.
Side-by-Side Comparison
| Metric | GNOM | VXUS | Winner |
|---|---|---|---|
| Expense Ratio | 0.50% | 0.05% | |
| AUM | $79M | $156.5B | |
| Dividend Yield | 1.15% | 2.60% | |
| Holdings | 52 | 8,747 | |
| YTD Return | +30.50% | +15.00% | |
| 1Y Return | +69.54% | +26.87% | |
| 3Y Return (annualized) | +10.14% | +19.79% | |
| 5Y Return (annualized) | -8.28% | +9.26% | |
| Volatility (annualized) | 29.8% | 15.1% | |
| Max Drawdown | -75.0% | -39.9% | |
| Fund Family | Global X by mirae Asset | Vanguard (US) | |
| Category | Equity | Equity | |
| Inception | Apr 5, 2019 | Jan 26, 2011 |
GNOM vs VXUS Performance
Global X Genomics & Biotechnology ETF (GNOM) is a ETF from Global X by mirae Asset and Vanguard Total International Stock ETF (VXUS) is a ETF from Vanguard (US). Over the past year GNOM returned +69.54% while VXUS returned +26.87%. Year to date, GNOM is up 30.50% versus a gain of 15.00% for VXUS.
Over three years, GNOM compounded at +10.14% per year against +19.79% for VXUS; over five years the annualized figures are -8.28% and +9.26% respectively. Across the full 7-year window we track, VXUS has the edge at +4.88% annualized vs -0.22%. Past performance does not guarantee future results.
Risk: Volatility and Drawdowns
GNOM has been the more volatile fund, with annualized monthly volatility of 29.8% compared with 15.1% for VXUS. Lower volatility generally means a smoother ride, though it often comes with lower long-run returns.
The deepest peak-to-trough decline in our data was -75.0% for GNOM and -39.9% for VXUS. Drawdown depth is worth weighing if you expect to sell during market stress rather than ride it out.
The two funds' monthly returns correlate at 0.59. They move independently enough that combining them can meaningfully diversify a portfolio.
Fees and Cost Over Time
GNOM charges 0.50% per year while VXUS charges 0.05%. On a $10,000 position that is $50 vs $5 annually, a gap of $45 per year that compounds over a long holding period. On income, GNOM currently yields 1.15% against 2.60% for VXUS.
Holdings Overlap
GNOM and VXUS share 0 holdings out of 7896 unique holdings combined, representing a 0.0% weight overlap.
Moderate overlap means holding both could provide meaningful diversification benefits.
Frequently Asked Questions
Which is cheaper, GNOM or VXUS?
GNOM has an expense ratio of 0.50% while VXUS charges 0.05%. VXUS is the cheaper option. On a $10,000 investment, that is $45 per year of difference.
Which performed better, GNOM or VXUS?
Over the past year GNOM returned +69.54% vs +26.87% for VXUS, so GNOM leads on 1-year performance. Over the longest common window we track (7 years), GNOM annualized -0.22% vs +4.88% for VXUS. Past performance does not guarantee future results.
Which is riskier, GNOM or VXUS?
GNOM has been the more volatile fund at 29.8% annualized versus 15.1% for VXUS. Worst drawdown: GNOM -75.0% vs VXUS -39.9%.
Should I hold both GNOM and VXUS?
GNOM and VXUS have a monthly-return correlation of 0.59, so combining them can provide real diversification depending on your allocation goals.
What is the holdings overlap between GNOM and VXUS?
GNOM and VXUS share 0 common holdings with a 0.0% weight overlap. Combined, they hold 7896 unique securities.
Which pays a higher dividend, GNOM or VXUS?
GNOM yields 1.15% while VXUS yields 2.60%, so VXUS currently pays the higher dividend yield.
Popular ETF Comparisons
Get Full ETF Analytics
Access complete holdings data, overlap analysis, screener tools, and more with FundXLS.